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Abstract
The basis of eukaryotic complexity is an intricate
genetic architecture where parallel systems are in-
volved in tuning gene expression, via RNA-DNA,
RNA-RNA, RNA-protein, and DNA-protein inter-
actions. In higher organisms, about 97% of the
transcriptional output is represented by noncoding
RNA (ncRNA) encompassing not only rRNA, tRNA,
introns, 5¢ and 3¢ untranslated regions, transposable
elements, and intergenic regions, but also a large,
rapidly emerging family named microRNAs. Mi-
croRNAs are short 20-22-nucleotide RNA molecules
that have been shown to regulate the expression of
other genes in a variety of eukaryotic systems. Mi-
croRNAs are formed from larger transcripts that fold
to produce hairpin structures and serve as substrates
for the cytoplasmic Dicer, a member of the RNase III
enzyme family. A recent analysis of the genomic
location of human microRNA genes suggested that
50% of microRNA genes are located in cancer-asso-
ciated genomic regions or in fragile sites. This re-
view focuses on the possible implications of
microRNAs in post-transcriptional gene regulation
in mammalian diseases, with particular focus on
cancer. We argue that developing mouse models for
deleted and/or overexpressed microRNAs will be of
invaluable interest to decipher the regulatory net-
works where microRNAs are involved.
What are microRNAs?
MicroRNAs are a group of small noncoding RNA
(ncRNA) molecules, distinct from but related to
small interfering RNAs (siRNAs), that have been
identified in a variety of organisms (for reviews see
He and Hannon 2004; Bartel 2004). These small
2022-nucleotide (nt) RNAs are transcribed as
parts of longer molecules several kilobases (kb) in
length that are processed in the nucleus into hair-
pin RNAs of 70100 nt by the double-stranded
RNA-specific ribonuclease Drosha (Cullen 2004).
The hairpin RNAs are transported to the cyto-
plasm, via an exportin 5-dependent mechanism,
where they are digested by a second, double-stran-
ded specific ribonuclease called Dicer. These
mechanisms are described in more detail in the
next section. In animals, single-stranded microR-
NA binds specific messenger RNA (mRNA)
through sequences that are significantly, though
not completely, complementary to the target
mRNA, mainly to the 3¢ untranslated region (3¢
UTR). By a mechanism that is not fully charac-
terized, the bound mRNA remains untranslated,
resulting in reduced levels of the corresponding
protein; alternatively, the bound mRNA can be
degraded, resulting in reduced levels of the corre-
sponding transcript (Fig. 1).
The central dogma of classical biology is that
genetic information flows from DNA to RNA to
proteins. Therefore, ‘‘genes’’ are synonymous with
proteins and a gene is defined as a protein-coding
region with associated regulatory signals (Mattick
2003). MicroRNAs represent new stars in the gene
regulation galaxy, and there is a strong interest
among researchers in different fields to understand
their mechanism of action and identify their targets.
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ReviewThe definition of a gene in the genomics era should
be expanded to be a ‘‘transcription unit’’ or ‘‘a
complete chromosomal segment responsible for
making a functional product’’ (Okazaki et al. 2002).
Because of the complex genetic architecture of
eukaryotic cells, this definition is still not complete,
190 C. SEVIGNANI ET AL:M AMMALIAN MICRORNASand additional issues such as overlap, alternative
splicing, or transcribed pseudogenes have to be
considered (Snyder and Gerstein 2003). Thus, the
term ‘‘gene’’ could be expanded to include
microRNAs (and other functional ncRNAs).
The number of microRNAs is growing rapidly,
especially after using ‘‘in silico’’ cloning (Table 1).
One such bioinformatics tool is MiRscan which
ranks predicted hairpins that are conserved in the
genome of two related animals based on several
criteria (Lim et al. 2003). Initially, it was estimated
that there could be from 200 to 1000 microRNA
genes in the mammalian genome (1%3% of
known genes are represented by microRNAs). Today
the number of microRNAs, including those elec-
tronically cloned, is over 1000 and still growing
(Berezikov et al. 2005; Xie et al. 2005). Mammalian
microRNA genes have been distinguished by using
the prefix mir followed by a number; the prefixes lin
and let refer to microRNAs originally identified in C.
elegans (see below). The MicroRNA Registry web-
site contains a comprehensive list of microRNAs
from all species (Table 1).
How are microRNAs produced?
More than a decade ago, Ambros and colleagues
discovered that lin-4, a gene known to control the
timing of C. elegans larval development, does not
code for any protein but instead codes for a pair of
small RNAs (Lee et al. 1993). One RNA is longer
(70 nt) and can fold in a stem-loop structure, as the
precursor of the shorter RNA (22 nt). The Ambros
and Ruvkun laboratories later discovered that the
small lin-4 RNAs had an antisense complementarity
to multiple sites in the 3¢ UTR of the lin-14 protein-
coding gene (Lee et al. 1993; Wightman et al. 1993).
The sequence complementarity between the non-
coding lin-4 RNA and the 3¢ UTR of the protein-
coding lin-14 gene suggested that lin-4 regulated
translation of lin-14 by binding to the 3¢ UTR. It was
later shown that lin-4 regulated the lin-14 gene
during early larval development as well as the lin-28
gene during late larval development by a mechanism
involving RNA-RNA binding that led to suppression
of translation (Moss et al. 1997). The shorter lin-4
RNA is now known as the founding member of the
Table 1. MicroRNA websites for ‘‘in silico’’ cloning, target identification, and the Registry
Program URL Species
‘‘In silico’’ cloning
MiRscan http://genes.mit.edu/mirscan C. elegans, Human
MiRseeker tomancak@mpi-cbg.de
Dr. Pavel Tomancak (personal communication) Drosophila
Target identification
TargetScan http://genes.mit.edu/targetscan Vertebrates
Diana MicroT http://www.diana.pcbi.upenn.edu/cgi-bin/micro_t.cgi Human/Mouse
miRNAtarget prediction http://www.russell.embl.de/miRNAs/ Drosophila
miRanda http://www.microrna.org/miranda.html Drosophila/Human
RNAhybrid http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/ Drosophila
RNAcalibrate
RNA effective
mirnaviewer http://cbio.mskcc.org/mirnaviewer/ Human
Pictar http://pictar.bio.nyu.edu/ Human
MicroRNAs database
The MicroRNAs Registry http://www.sanger.ac.uk/Software/Rfam/mirna/index.shtml All
Fig. 1. Biogenesis of microRNAs and hypothetical mecha-
nisms in regulation of gene expression. RNA polymerases
II and III are believed responsible for microRNA tran-
scription, although a recent publication indicates that
polymerase II is the main RNA polymerase for microRNA
transcription (Lee et al. 2004). (A) Exonic microRNAs in
sense orientation as a part of annotated host genes are
transcribed as parts of longer molecules that are processed
in the nucleus into hairpin RNAs of 70100 nt by the
dsRNA-specific ribonuclease Drosha. The hairpin RNAs
are transported to the cytoplasm where they are digested by
a second, double-strand specific ribonuclease called Dicer.
In animals, single-stranded miRNA binds specific mRNA
through sequences that in most of cases are significantly,
though not completely, complementary to the target
mRNA. (B) The excision of intronic microRNAs out of the
precursors is completed through the process of RNA
splicing, followed by Dicer digestion. MicroRNAs are fi-
nally incorporated into an RNA-induced silencing complex
(RISC) to induce translation suppression or degradation
depending of the degree of complementary with the target
mRNA. (C, D) Exonic and intronic microRNAs in anti-
sense orientation as a part of annotated host genes can be
trancribed as independent transcription units. The mature
microRNA sequence, in our hypothetical mechanisms, can
lead to translation or transcription suppression of the host
gene of other target mRNAs. MicroRNA genes located in
intergenic regions or gene deserts are transcribed as inde-
pendent transcription units and their biogenesis can be
described as in A.
b
C. SEVIGNANI ET AL:M AMMALIAN MICRORNAS 191class of microRNA genes (Lagos-Quintana et al.
2001; Lau et al. 2001; Lee and Ambros 2001).
The majority of microRNAs (70%) are located in
introns and/or exons, and approximately 30% are
located in intergenic regions (Rodriguez et al. 2004)
(Fig. 1). The first group of microRNAs from introns
and/or exons is oriented in sense with the exon-
coding ‘‘host’’ gene and, therefore, may be tran-
scribed as part of annotated genes. The second group
of microRNAs are transcribed from intergenic re-
gions or gene deserts (LagosQuintana et al. 2001;
Lau et al. 2001; Lee and Ambros 2001), indicating
that they form independent transcription units (Lee
et al. 2002). The third group of microRNAs are de-
rived from introns and/or exons of annotated genes
but are transcribed in the antisense orientation,
suggesting that they too form their own transcrip-
tion units. Tightly linked microRNAs may be tran-
scribed as polycistronic messengers; however,
microRNAs separated by more than 50 kb tend to
represent independent transcription units (Basker-
ville and Bartel 2005). RNA polymerases II and III are
candidates for pri-microRNAs (primary) transcrip-
tion (Fig. 1).
In animals (Fig. 1), the first step in microRNA
maturation is the nuclear cleavage of the several-kb-
long pri-microRNA, which releases an approxi-
mately 70-nt, cropped, hairpin-shaped intermediate
known as pre-microRNA (precursor). The Drosha
RNase III endonuclease is responsible for this nu-
clear processing (Bartel 2004; Lee et al. 2003; Zeng
et al. 2005). Drosha cannot cleave without a partner,
forming a complex with DGCR8 (a product of the
DiGeorge syndrome critical region gene 8), which
contains two double-stranded RNA-binding domains
(Han et al. 2004; Tomari and Zamore 2005). The
hairpin precursor is actively transported from the
nucleus to the cytoplasm by exportin 5 (Yi et al.
2003; Lund et al. 2004). A second enzyme, an RNase
III endonuclease called Dicer, is responsible for
generating an approximately 21-nt, short, single-
stranded RNA that is the mature microRNA (Lee
et al. 2003). Dicer was first recognized for its role in
generating siRNAs that mediate RNA interference
(RNAi) (Bernstein et al. 2001). After cleavage in the
cytoplasm, the microRNA pathways of plants and
animals share some other steps with RNA silencing,
and the cleavage products become incorporated as
single-stranded RNAs into the ribonucleoprotein
RNA-induced silencing complex RISC (Hammond
et al. 2000). The RISC has been purified from fruit fly
and human cells and in both cases contains a
member of the Argonaute protein family (essential
for gene silencing in Caenorhabditis elegans,
Neurospora, and Arabidopsis), which is thought to
be a core component of the complex (Hammond
et al. 2001; Mourelatos et al. 2002). Once incorpo-
rated in the cytoplasmic RISC complex, the micr-
oRNA will specify cleavage if the mRNA has
sufficient complementarity to the microRNA, or it
will block translation if the microRNA does not
have sufficient complementarity, resulting in re-
duced expression of the corresponding protein.
MicroRNA regulation of the microRNA:mRNA du-
plex is mediated mainly through multiple comple-
mentary sites in the 3¢ UTRs, but there are many
exceptions. MicroRNAs may also bind the 5¢ UTR
and/or the coding region of mRNAs, resulting in a
similar outcome (Fig. 1).
How are microRNAs working?
The functions of microRNA are various, such as the
control of leaf and flower development in plants
(Aukerman and Sakai 2003) or the modulation of
hematopoietic lineage differentiation in mammals
(Chen et al. 2004). Several groups have uncovered
roles for microRNAs in the coordination of cell
proliferation and cell death during development and
in stress resistance and fat metabolism (Ambros
2003). For example, the Drosophila microRNA gene
(mir-14) suppresses cell death and is required for
normal fat metabolism (Xu et al. 2003), while the
bantam locus encodes a developmentally regulated
microRNA that controls cell proliferation and regu-
lates the proapoptotic gene hid in Drosophila
(Brennecke et al. 2003). It was recently shown that,
in addition to their regulatory functions, cellular
microRNAs mediate antiviral defenses in human
cells (Lecellier et al. 2005).
However, the function of most microRNAs is
not known. The antisense single-stranded microR-
NAs can bind specific mRNA transcripts through
sequences that are significantly, though not com-
pletely, complementary to the target mRNA. This
process is also known as post-transcriptional gene
regulation (PTGS). Some microRNAs can downre-
gulate large numbers of target mRNAs (Lim et al.
2005), and it has been speculated that microRNAs
could regulate approximately 30% of the human
genome (Bartel 2004). MicroRNAs seem to be
responsible for fine regulation of gene expression,
‘‘tuning’’ the cellular phenotype during delicate
processes like development and differentiation in all
organisms, from plants to mammals. Many mi-
croRNAs are conserved in sequence between dis-
tantly related organisms (see The MicroRNA
Registry in Table 1), suggesting that these molecules
participate in essential processes (Lagos-Quintana et
al. 2003; Pasquinelli et al. 2000). One example is the
192 C. SEVIGNANI ET AL:M AMMALIAN MICRORNAScluster of mir-16-1 and mir-15a, which is highly
conserved in nine of ten primate species (Berezikov
et al. 2005).
Target identification has been hampered by the
fact that in animals, in contrast to plants,
microRNAs do not bind perfectly to their targets. A
few nucleotides typically remain unbound, yielding
complex secondary structures. Mammalian genes
can have more than one microRNA target site in
their 3¢ UTRs and one microRNA can target more
than one mRNA. Bioinformatics approaches have
been developed to search for the most thermody-
namically favorable microRNA:mRNA duplex
interactions (Table 1). Several computational proce-
dures such as DianaMicroT, TargetScan, and miR-
anda (Lewis et al. 2003; Kiriakidou et al. 2004;
Enright et al. 2003) are available to predict
microRNA targets. Another set of programs devel-
oped for target identification includes RNAhybrid,
RNAcalibrate, and RNAeffective (Rehmsmeier et al.
2004), which work by searching for the most ener-
getically favorable hybridization sites for the smaller
microRNA within the larger mRNA (Table 1). Only
a few target mRNAs have been experimentally pro-
ven and studied in vitro, but the numbers of such
confirmed interactions are expected to sharply in-
crease as prediction tools become more sophisti-
cated. Generally, the proven mRNA targets are
produced from different chromosomes as the corre-
sponding microRNAs (such as mir-19a on chromo-
some 13q31.3 having as a target the mRNA of the
PTEN tumor suppressor gene located on chromo-
some 10q23.3), but examples of microRNAs target-
ing ‘‘neighbor’’ exon-coding genes are also known.
An important example is that of mir-196, which
leads to the cleavage and degradation of mRNA from
the homeobox gene HOXB8 (Yekta et al. 2004).
MicroRNAs are not the only ncRNA sequences
that have been shown to play a role in the regulation
of gene expression. A large set of ncRNAs are known
as ‘‘gene regulators’’ and the list in mammals in-
cludes Air, H19, Ipw, NTT, Tsix and XIST (Table 2).
These ncRNAs have a variety of functions, from
potential involvement in the imprinting process to
X-chromosome inactivation in mammals. It is likely
that other ncRNAs will be found, albeit with addi-
tional effects on critical biological processes.
MicroRNAs and human cancer
Several articles have now shown the possibility that
small ncRNAs play an important role in cancer
(Table 3). We show in Fig. 2 diagrams of several
proposed mechanisms for microRNAs as cancer
players (Calin et al. 2004a; McManus 2003). Inher-
ited or somatic mutations, amplification, deletion,
or epigenetic silencing of microRNA genes may not
only cause certain cancers but may contribute to an
individual’s risk of developing cancer (Fig. 2).
The first report linking microRNAs and cancer
(Calin et al. 2002) involved chronic lymphocytic
leukemia (CLL), the most common form of adult
leukemia in the Western world. Hemizygous and/
or homozygous loss at chromosome 13q14 occurs
in more than half of CLL cases. Loss of chromo-
some 13q14 is also found in more than 50% of
mantle cell lymphomas (Stilgenbauer et al. 1998),
in approximately 30% of multiple myeloma (Elne-
naei et al. 2003), and in approximately 70% of
prostate cancers (Dong et al. 2001), suggesting that
one or more tumor suppressor genes located at
chromosome 13q14 are involved in the pathogen-
esis of human tumors (Calin et al. 2002). However,
detailed genetic analysis, including extensive loss
of heterozygosity (LOH), mutation, and expression
studies failed to demonstrate the consistent
involvement of any of the 12 protein-coding genes
located in or close to the deleted region. A cluster
of two microRNAs, mir-15a and mir-16-1, was
found within the minimal region of deletion (30
kb) at 13q14 and to be deleted or downregulated in
approximately 70% of CLL samples. Similarly, a
t(12;13) chromosome translocation in a patient
with CLL was found to decrease the mir-15a and
mir-16-1 precursors (Calin et al. 2002). A similar
cluster of microRNAs, named mir-15b and mir-16-
2, is located on human Chromosome 3 but is ex-
pressed at very low levels in lymphoid cells.
The first genome-wide systematic search for
correlations between the genomic positions of mi-
croRNAs and cancer-associated genomic regions
(CAGRs) provided a catalog of microRNAs possibly
involved in cancer (Calin et al. 2004a). One hundred
eighty-six microRNAs were mapped to the human
genome and compared with the location of previ-
ously reported nonrandom genetic alterations iden-
tified in human tumors and with cloned fragile sites
(FRAs). Minimal regions of LOH are suggestive of
the presence of tumor suppressor genes, minimal
regions of amplification for the presence of oncoge-
nes, while common breakpoint regions are found
close to both types of cancer genes. Some common
fragile sites predispose to DNA instability in cancer
cells; indeed they are preferential sites of sister
chromatid exchange, translocation, deletion, ampli-
fication, or integration of plasmid DNA and tumor-
associated viruses. This study concluded that 19%
(35 of 186) of microRNAs are located inside or near
FRAs and the relative incidence of microRNAs in-
side FRAs occurred at a rate nine times higher than
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194 C. SEVIGNANI ET AL:M AMMALIAN MICRORNASin non-FRAs. A significant proportion, 52.5% (98 of
186), of microRNAs are in CAGRs described in a
variety of tumors such as lung, breast, ovarian, co-
lon, gastric, and hepatocellular carcinoma, as well as
leukemias and lymphomas.
Little was known about the expression levels of
microRNA genes in normal and neoplastic cells
until 2002. To assess cancer-specific expression
levels for hundreds of microRNAs is time-con-
suming and requires a large amount of total RNA
and the use of radioactive isotopes. cDNA micro-
arrays are useful tools for identifying different pat-
terns of expression in a large number of samples.
The first developed oligonucleotide microRNA
microarray chips (Liu et al. 2004a), containing
hundreds of human precursor and mature microR-
NA probes, identified distinct patterns of microR-
NA expression in human and mouse tissues
(tissue-specific microRNA expression signatures).
Another method to determine microRNA expres-
sion levels involves the use of a bead-based flow
cytometric technique (Lu et al. 2005a). Since the
development of these two methods of assessing
global microRNA expression, several commercially
Fig. 2. MicroRNAs as cancer players. MicroRNAs may act as tumor suppressors or oncogenes in cancer. Orange triangles
represent mir promoters and blue ovals represent their corresponding mir genes. Orange rectangles represent promoters of
protein-coding genes and blue rectangles represent the actual coding sequences of their corresponding genes. One
mechanism for the downregulation of ‘‘suppressor-microRNAs’’ that has been identified is (A) Homozygous deletion of
microRNA coding regions, as exemplified by deletion of the mir-15a/mir-16-1 cluster in B-CLL (Calin et al. 2002).
Hypothetical mechanisms for downregulation of ‘‘suppressor-microRNAs’’ in cancer include (B) the combination of
deletion plus promoter hypermethylation, and (C) deletion plus mutation. Mechanisms for the upregulation of ‘‘onco-
microRNAs’’ that have been identified are (D) amplification and overexpression of pre-microRNAs, as exemplified by mir-
155/BIC in children’s Burkitt’s lymphoma (Metzler et al. 2004), and (E) translocations of either protoconcogenes near the
promoter of microRNAs or translocation of microRNAs near the promoters of oncogenes (modified after Calin et al. ( )
2004 PNAS, National Academy of Sciences, Washington, DC, USA).
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oRNA gene expression profiling.
Global analysis of microRNA gene expression
has shown that these profiles can be used to classify
the developmental lineage and differentiation state
of tumors; in addition, microRNA profiles appear to
provide a distinct signature for tumors which is
more precise than that provided by protein-coding
genes (Lu et al. 2005a). These findings lead to a un-
ique opportunity to use these microRNA profiles for
tumor diagnostics.
Specific differences in microRNA expression
between CLL samples and normal CD5+ B cells, the
latter representing normal cells corresponding to
CLL malignant cells, were found (Calin et al. 2002).
Two clusters of CLL samples were identified that
were associated with the presence or absence of
ZAP-70 expression, a predictor of early disease pro-
gression. Low levels of ZAP-70 (identified by both
Western blots and flow cytometry) are associated
with good prognosis. Two microRNA signatures
were associated with the presence or absence of
mutations in the expressed immunoglobulin vari-
able-region genes or with deletions at chromosome
13q14, respectively. Different microRNA expression
profiles suggested that specific microRNAs can have
prognostic significance in CLL, thus expanding the
spectrum of prognostic markers (Calin et al. 2004b).
A unique microRNA expression signature composed
of 13 genes can differentiate cases with low or high
ZAP-70 expression and cases with unmutated or
mutated IgVH. Furthermore, both mir-15a and mir-
16-1 are members of this signature, suggesting an
important functional role in the pathogenesis of
human CLL (Calin et al. 2005).
The list of microRNAs reported to be involved in
cancer is growing continuously (Table 3). One report
showed that mir-143 and mir-145 exhibited reduced
levels of the mature microRNA in colon cancer pa-
tients, colon cancer cell lines, and precancerous
adenomatous polyps when compared to normal tis-
sues by Northern blot (Michael et al. 2003). On the
contrary, levels of unprocessed hairpin precursors
were not altered. It is possible that the reduced
accumulation of the mature microRNA reflects
early changes in neoplastic cells or that this deple-
tion is related to their activity in binding and inac-
tivating target mRNAs in the cytoplasm. Putative
targets (human mRNAs that display imperfect
complementarity of 70%100%) for mir-143 and
mir-145 include several genes that encode compo-
nents of signal transduction pathways (such as RAF,
RHO, and G-proteins) and chromatin-mediated
control of gene expression were found by computer
search (Table 3).
In an independent study, it was shown that mir-
143 regulates adipocyte differentiation (Esau et al.
2004). When antisense oligonucleotides (ASOs) tar-
geting human microRNAs were transfected into
cultured human primary subcutaneous preadipo-
cytes, mir-143 was upregulated as adipocytes differ-
entiated. Bioinformatics approaches predicted
several putative microRNA targets. ERK5/BMK1
(which promotes cell growth and proliferation in
response to tyrosine kinase signaling) was predicted
to be a mir-143 target and, in fact, ERK5 protein
levels were upregulated in mir-143 ASO-treated
adipocytes. However, because each microRNA can
regulate multiple target genes, mir-143 could di-
rectly inhibit ERK5 by binding the 3¢ UTR of ERK5,
or indirectly by binding to another target gene (Esau
et al. 2004).
Another study reported reduced expression of the
let-7 microRNA in human lung cancer and the corre-
lation with clinicopathologic features (Takamizawa
et al. 2004). Reduction in the expression (>80%) levels
of let-7 was observed in 60% (12 of 20) of cancer cell
lines and 44% (7 of16) of lung tumors when compared
with normal lung tissues by Northern blots. The re-
duced expression was significantly associated with
shortened survival of patients after potentially cura-
tiveresection.Onehundredforty-threecaseshadbeen
followed for more than five years after surgery and
wereusedtostudytheprognosticsignificanceoflet-7.
One hundred forty-three non-small-cell lung carci-
noma (NSCLC) cases were classified into clusters 1
and 2 (cluster 1 with low let-7 expression and higher
diseasestages;cluster2withhighlet-7expressionand
lower disease stages). The difference in postoperative
survival between clusters 1 and 2 was highly signifi-
cant. In addition, overexpression of let-7 in the A549
lung adenocarcinoma cell line inhibited lung cancer
cell growth in vitro (Takamizawa et al. 2004). Several
observations led to the conclusion that let-7 acts as a
tumor suppressor gene in lung tissue. Several let-7
familymembers,includinglet-7a-2,let-7c,andlet-7g,
have been mapped to minimally deleted regions in
lung cancers (Calin et al. 2004a). Let-7 expression is
lower in lung tumors than in normal lung tissue,
while RAS protein is significantly higher in lung tu-
mors (Johnson et al. 2005). Finally, expression of the
RAS oncogene is regulated by let-7, and overexpres-
sionoflet-7hasbeenshowntoinhibitlungtumorcell
line growth (Johnson et al. 2005).
High expression of human BIC RNA has been
found in Hodgkin’s lymphoma (van den Berg 2003).
In contrast, an analysis of non-Hodgkin’s lym-
phoma (NHL) did not reveal any remarkable
upregulation of BIC expression. The BIC locus was
originally identified as a common retroviral inte-
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lymphomas (Tam et al. 1997). The human BIC lo-
cus also encodes a microRNA, mir-155 (Tam 2001;
Lagos-Quintana et al. 2002). The conditio sine qua
non for the development of Burkitt’s lymphoma is
activation of the MYC oncogene, mostly by chro-
mosomal translocations in which MYC is juxta-
posed next to an immunoglobulin enhancer. But
activation of MYC alone is not sufficient for full
malignancy; in fact, MYC cooperates with other
oncogenes. Further studies involving a human B-
cell line that contains a tetracycline-regulated c-
MYC gene have shown that overexpression of the c-
MYC oncogene leads to increased expression of six
microRNAs, two of which are mir-17-5p and mir-
20a (O’Donnell et al. 2005). These microRNAs were
found to negatively regulate expression of the E2F1
transcription factor. Since E2F1 is also a target of c-
MYC, these results allude to an intricate network
that exquisitely regulates gene expression, ulti-
mately controlling cell proliferation.
In childhood Burkitt’s lymphoma, there has been
reported a 100-fold upregulation of the hairpin pre-
cursor mir-155 (Metzler et al. 2004). It could be
speculated that mir-155 directly downregulates one
of the MYC antagonists such as MAD1, MXI1, or
ROX/MNT. Accumulation of mir-155 and BIC RNA
was also reported in other B-cell lymphomas (Eis
et al. 2005).
It was recently reported that mir-21 is upregu-
lated in both human glioblastomas as well as cul-
tured glioblastoma multiforma cells and cell lines
compared to primary astrocyte cultures derived from
normal tissue; inhibition of mir-21 expression led to
the activation of caspases and cell death in vitro
(Chan et al. 2005). These data suggest a role for mir-
21 in malignant glioblastoma, most likely by influ-
encing expression of genes involved in apoptosis
(Chan et al. 2005).
Overall, the studies to date clearly implicate a
causative role for microRNAs in human cancer. The
intricate network of signals regulating gene expres-
sion requires a delicate balance between protein-
coding genes and microRNA genes. Disruption of
this delicate relationship by mutation can tip the
balance in favor of the development of cancer.
MicroRNAs and other human diseases
Several articles have been published showing a
probable link between microRNAs and other human
diseases, but the precise mechanisms are still not
known (Table 4). Fragile X syndrome is the most
common inherited mental retardation disease. In the
U.S., conservative estimates report that fragile X
syndrome affects approximately 1 in 4000 males and
1 in 8000 females; the rate of the female carrier state
has been estimated to be as high as 1 in 250 and the
male carrier state has been estimated to be 1 in 1000.
The fragile X mental retardation protein (FMRP) is
an RNA-binding protein that can function as a
translational suppressor. FMRP can form a messen-
ger ribonucleoprotein (mRNP) complex, interacting
with specific RNA transcripts and proteins. The
complex is transported out of the nucleus and into
the cytoplasm, where it can either associate with the
ribosome or interact with RISC; in both cases, it will
lead to protein synthesis regulation. FMRP can
interact with microRNAs and other components of
the microRNA pathways, including Dicer and the
mammalian ortholog of Argonaute 1 (AGO1), a
component of RISC (Jin et al. 2004; Peng et al. 2004).
Spinal muscular atrophy (SMA) is an inherited
neurodegenerative disease with neuromuscular
symptoms. Survival of Motor Neurons protein
(SMN) is a component of the SMN complex that has
critical functions in the assembly and restructuring
of diverse ribonucleoprotein (RNP) complexes.
Components of the SMN complex (GEMIN3 and
GEMIN4) are also in a separate complex that con-
tains eIF2C2, a member of the Argonaute protein
family. This novel complex contains numerous mi-
croRNAs that form novel RNPs named miRNPs
(Mourelatos et al. 2002). This link between mi-
croRNAs and a devastating neurodegenerative dis-
ease is intriguing and will be of great interest to
determine what effect these microRNAs have on
miRNPs in SMA patients.
DiGeorge syndrome is characterized by a few
specific cardiac malformations, facial deformity, and
certain endocrine and immune anomalies. The
DGCR8 (DiGeorge syndrome critical region gene 8)
protein and Drosha interact in human cells. Knock-
Table 4. MicroRNAs and other human diseases
Disease Protein alteration References
Fragile X syndrome Loss of expression of the fragile X mental retardation
protein (FMRP)
Peng et al. (2004)
Spinal muscular atrophy (SMA) Reduction of expression in Survival of Motor Neurons
protein (SMN)
Mourelatos et al. (2002)
DiGeorge syndrome 22q11.21 microdeletion with loss of expression of DGCR8 Landthaler et al. (2004)
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523-fold accumulation of some pri-microRNAs,
confirming a role in mediating the genesis of
miRNAs from the pri-microRNA transcript (Landt-
haler et al. 2004; Gregory et al. 2004).
MicroRNAs have also been shown to regulate
insulin secretion (Poy et al. 2004). Overexpression of
mir-375 (a pancreatic islet-specific microRNA) sup-
presses glucose-induced insulin secretion, and,
conversely, inhibition of endogenous mir-375 by
ASOs enhances insulin secretion in murine pancre-
atic a- and b-cell lines. Bioinformatics approaches
predicted several putative targets with a potential
role in insulin secretion such as MAPK4, MKI1,
VTI1A, and MTPN; the last two proteins are known
to be involved in vesicle transport of neurons and in
neurotransmitter release.
These studies represent the beginning links be-
tween microRNAs and human disease. Further
investigations are likely to reveal the involvement of
additional microRNAs and their targets in simple
and complex genetic diseases.
Mouse models for microRNA studies
Almost all mammalian microRNAs are highly con-
served and more than 220 mouse microRNAs were
cloned by conventional methods (LagosQuintana
et al. 2002; Seitz et al. 2004) (see The MicroRNA
Registry in Table 1). It has been shown that a tissue-
specific microRNA dominates the population of ex-
pressed microRNAs, suggesting important roles in
tissue differentiation. For example, in mouse liver,
mir-122a and mir-122b represent 72% of all cloned
microRNAs; these microRNAs were not detected in
the other tissues analyzed. In spleen, mir-143 was
the most abundant microRNA. In colon, mir-142
was cloned several times; however, because of the
strong RNase activity in small intestine and pan-
creas, too few microRNA sequences were obtained
from these tissues to reach statistical significance.
Using a microRNA microarray approach, micr-
oRNA expression was analyzed in 17 mouse organs
and tissues (Babak et al. 2004). More than half of the
78 microRNAs detected were expressed in specific
adult tissues. The results were confirmed by
Northern blotting and were consistent with
microRNA expression data reported in the literature.
Furthermore, this study is consistent with
microRNA expression profiling in human tissues
(Liu et al. 2004). For example, seven of eight
microRNAs were brain-specific in both mice and
humans.
Another report gave new light on the world of
microRNA regulation in humans and mice (Seitz
et al. 2004). By bioinformatics approaches, 46 po-
tential microRNAs located in the human imprinted
14q32 domain have been identified. Forty of these
microRNAs are clustered and most of them are ar-
ranged in tandem arrays. The majority of these genes
map within an approximately 40-kb region, making
it the largest microRNA cluster that has been de-
scribed. In mouse, this microRNA cluster is con-
served at the homologous region on Chromosome
12. The detected microRNAs are expressed in em-
bryos and placenta, whereas in the adult their
expression pattern is limited to the brain. Expression
of these microRNAs comes solely from the mater-
nally inherited chromosome, which is imprinted.
Regulation of their expression is dictated by a region
located approximately 200 kb upstream from the
microRNA cluster (Seitz et al. 2004).
Research has shown how microRNAs have a role
in fine-tuning specific Hox mRNA expression pat-
terns during mouse development (Mansfield et al.
2004). A novel approach was used to monitor micr-
oRNA tissue-specific expression patterns during
embryogenesis. Until now, microRNA expression
studies were done by Northern blots, tissue-specific
RNA cloning, and microarrays, but all of these
methods are not useful for displaying spatiotemporal
expression patterns. In situ hybridization methods
are still difficult to adapt in vertebrate embryos be-
cause of the small size of microRNAs. An alterna-
tive approach, previously used in Drosophila
melanogaster, was used where several reporter
transgenes (‘‘sensors’’) were made to detect
microRNAs in the embryo. The sensor was a con-
stitutively expressed reporter gene (lacZ) containing
microRNA complementary sequences in the 3¢ UTR.
In cells lacking the corresponding microRNAs, the
reporter transgene is stable and will express b-
galactosidase. In contrast, cells expressing the cor-
responding microRNA degrade the lacZ message by
an RNA interfering pathway (RNAi), thus resulting
in absence of b-galactosidase activity.
To prove the biological significance of
microRNAs in human biology and in cancer in
particular, the development of mouse models for
deleted and/or overexpressed microRNAs will be of
invaluable interest for deciphering the regulatory
networks where microRNAs are involved. Several
groups have started this task by disrupting Dicer1 in
mice. Loss of Dicer1 by replacement of exon 21
with a neomycin-resistance cassette leads to
lethality early in embryogenesis at day 7.5 of
development; Dicer1-null embryos were found to be
depleted of pluripotent stem cells (Bernstein et al.
2003). Another group generated Dicerex1/2 mice
that have a deletion of the amino acid sequences
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(Yang et al. 2005). Dicerex1/2 homozygous embryos
died between days 12.5 and 14.5 of gestation, again
demonstrating that Dicer is necessary for normal
mouse development. In addition, blood vessel for-
mation and maintenance in Dicerex1/2 embryos
and yolk sacs were severely compromised, with al-
tered expression of Vegf, Flt1, Kdr, and Tie1 being
detected in the mutant embryos. This study sug-
gests that Dicer has a role in embryonic angiogen-
esis, probably through processing of microRNAs
that regulate expression levels of key angiogenic
regulators (Yang et al. 2005).
Although Dicer-null embryonic stem (ES) cells
are viable, they are defective in RNA interference
(RNAi) and the generation of microRNAs
(Kanellopoulou et al. 2005). These mutant ES cells
displayed severe defects in differentiation both in
vitro and in vivo. An increase in centromeric repeat
transcripts was detected, whereas the expression of
homologous small double-stranded RNAs was
markedly reduced in Dicer-deficient ES cells
(Kanellopoulou et al. 2005; Murchison et al. 2005).
Re-expression of Dicer in the knockout cells rescued
these phenotypes. These Dicer-deficient cells were
able to undergo gene silencing when provided with
synthetic siRNAs (Kanellopoulou et al. 2005;
Murchison et al. 2005), indicating that Dicer func-
tion is required for processing of microRNAs but not
required for the action of microRNAs once they are
produced. However, the status of cytosine methyla-
tion of centromeric satellite sequences remains in
question. Taken together, these studies suggest that
the essential role of Dicer in the production of ma-
ture microRNAs is central for biological processes in
mammalian organisms, ranging from stem cell dif-
ferentiation to the integrity and function of centro-
meric heterochromatin (Kanellopoulou et al. 2005).
Critical insights into the roles of individual
proteins of the microRNA processing machinery
have been provided by in situ hybridization studies
of Argonaute (Ago1-Ago4) family members in mouse
embryos (Liu et al. 2004b; Lu et al. 2005b). Studies in
embryos at days 9.514.5 of development have
shown that Argonaute family members are restricted
in both their temporal and spatial patterns of
expression. However, Ago2 shows the broadest
expression in mouse embryos and is consistent with
the fact that Ago2-deficient mice die early in devel-
opment (Liu et al. 2004b). Thus, the differential
expression of Ago family members suggests specific
roles for these proteins during organogenesis, most
likely involving the production of microRNAs that
are controlled at different times and in specific tis-
sues by the presence of Ago proteins.
One example of the use of mouse models to
study the roles of specific microRNAs in cancer was
provided by He et al. (2005). Their initial observation
was that the human mir 17-92 cluster was overex-
pressed by more than 5-fold in a majority of human
B-cell lymphomas. To determine whether overex-
pression of this cluster could drive B-cell lympho-
magenesis in mouse, the authors derived
hematopoeitic stem cells from a susceptible El-myc
transgenic mouse and transduced them with a ret-
rovirus carrying the mir 17-92 cluster. Injection of
transduced cells into normal mice resulted in
acceleration of the development of B-cell lympho-
mas; in contrast, other subsets of microRNAs ex-
pressed in these cells did not have similar effects (He
et al. 2005).
The ability to manipulate the genome of mice
coupled with the multitude of inbred strain back-
grounds provides invaluable tools to genetically
dissect the biological functions of individual mi-
croRNAs. Further studies of mouse models will
provide significant insights into the roles of different
microRNAs in development and disease processes.
Conclusions
A link between microRNAs and human diseases, in
particular, with cancer as focused on in this review,
has been recently shown. To better understand the
biological significance of microRNAs and of altera-
tions found in human diseases (such as the effect of
microRNA mutations or variations in expression)
the development of mouse models is mandatory.
Regulation of gene expression in the mammalian
genome, during development, differentiation, and
disease, is a complex and multitasked system. To
make transcripts instead of proteins is energetically
‘‘less expensive’’ for cells and could be the reason
why regulation at the RNA level is ‘‘cheaper’’ and
more efficient than at the protein level. Penetrance
in gene expression requires a fine regulation and
microRNAs could have a role in different pheno-
typic expressions of the same gene. The ability to
simultaneously regulate large sets of genes by a
single microRNA appears to be at the heart of
control of multiple pathways that include morpho-
genesis and cell fate decisions, response to infec-
tious organisms, and centromeric heterochromatin
structure. MicroRNAs appear to be at the center of
the balance between apoptosis and proliferation in
cancer cells and thus could provide novel ap-
proaches for therapeutics. MicroRNAs are small
stars in the genome galaxy with many surprises still
in store.
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